AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹283 Cr | ₹226 Cr | ₹173 Cr | ₹172 Cr | ₹157 Cr |
What is the latest Long Term Provisions ratio of AUROBINDO PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹283 Cr |
| Mar2024 | ₹226 Cr |
| Mar2023 | ₹173 Cr |
| Mar2022 | ₹172 Cr |
| Mar2021 | ₹157 Cr |
How is Long Term Provisions of AUROBINDO PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹283 Cr | 25.36 | |
| Mar2024 | ₹226 Cr | 30.67 | |
| Mar2023 | ₹173 Cr | 0.54 | |
| Mar2022 | ₹172 Cr | 9.34 | |
| Mar2021 | ₹157 Cr | - | |
Compare Long Term Provisions of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹88,122.5 Cr | -1.9% | 0.1% | 32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -1.9% |
0.1% |
32.1% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses